Author Correction: Enhanced NF-κB signaling in type-2 dendritic cells at baseline predicts non-response to adalimumab in psoriasis

Nat Commun. 2021 Dec 16;12(1):7358. doi: 10.1038/s41467-021-27447-6.

Rosa Andres-Ejarque¹, Hira Bahadur Ale¹, Katarzyna Grys^{1

2}, Isabella Tosi^{1

2}, Shane Solanky¹, Chrysanthi Ainali^{1

3}, Zeynep Catak^{1

2}, Hemawtee Sreeneebus^{1

2}, Jake Saklatvala⁴, Nick Dand⁴, Emanuele de Rinaldis^{2

5}, Anna Chapman⁶, Frank O Nestle^{1

2

5}, Michael R Barnes⁷, Richard B Warren^#⁸, Nick J Reynolds^#⁹, Christopher E M Griffiths^#⁸, Jonathan N Barker^#^{1

2}, Catherine H Smith^#^{1

2}, Paola Di Meglio^{10

11}; PSORT Consortium

PSORT Consortium:
Paola Di Meglio, Richard Emsley, Andrea Evans, Katherine Payne, Deborah Stocken

¹ St. Johns Institute of Dermatology, Kings College London, London, United Kingdom.
² NIHR Biomedical Research Centre, Guys & St Thomas NHS Foundation Trust & King's College London, London, UK.
³ DIGNOSIS Limited, London, UK.
⁴ Department of Medical and Molecular Genetics, Kings College London, London, UK.
⁵ Sanofi, Cambridge, MA, USA.
⁶ Dermatology Department, Queen Elizabeth Hospital, Lewisham and Greenwich NHS Trust, London, UK.
⁷ Centre for Translational Bioinformatics, William Harvey Research Institute, Queen Mary University of London, Charterhouse Square, London, UK.
⁸ Dermatology Centre, Salford Royal Hospital, The University of Manchester, Manchester Academic Health Science Centre, Manchester, UK.
⁹ Institute of Translational and Clinical Medicine, Newcastle University Medical School and Department of Dermatology, Royal Victoria Infirmary, Newcastle Hospitals NHS Foundation Trust, Newcastle upon Tyne, UK.
¹⁰ St. Johns Institute of Dermatology, Kings College London, London, United Kingdom. paola.dimeglio@kcl.ac.uk.
¹¹ NIHR Biomedical Research Centre, Guys & St Thomas NHS Foundation Trust & King's College London, London, UK. paola.dimeglio@kcl.ac.uk.

^# Contributed equally.

No abstract available

Publication types